Serum Proteome Alterations in Patients with Cognitive Impairment after Traumatic Brain Injury Revealed by iTRAQ-Based Quantitative Proteomics

Abstract

Background. Cognitive impairment is the leading cause of traumatic brain injury- (TBI-) related disability; however, the underlying pathogenesis of this dysfunction is not completely understood. Methods. Using an isobaric tagging for relative and absolute quantitation- (iTRAQ-) based quantitative proteomic approach, serum samples from healthy control subjects, TBI patients with cognitive impairment, and TBI patients without cognitive impairment were analysed to identify differentially expressed proteins (DEPs) related to post-TBI cognitive impairment. In addition, DEPs were further analysed using bioinformatic platforms and validated using enzyme-linked immunosorbent assays (ELISA). Results. A total of 56 DEPs were identified that were specifically related to TBI-induced cognitive impairment. Bioinformatic analysis revealed that a wide variety of cellular and metabolic processes and some signaling pathways were involved in the pathophysiology of cognitive deficits following TBI. Five randomly selected DEPs were validated using ELISA in an additional 105 cases, and the results also supported the experimental findings. Conclusions. Despite limitations, our findings will facilitate further studies of the pathological mechanisms underlying TBI-induced cognitive impairment and provide new methods for the research and development of neuroprotective agents. However, further investigation on a large cohort is warranted.

Quantitative proteomic characterization of microvesicles/exosomes from the cerebrospinal fluid of patients with acute bilirubin encephalopathy

“…MV/e are membrane-bound nanovesicles that serve as important mediators of intercellular communication by transporting molecular signals, including proteins, mrna and micrornas, between cells (20,21). High-throughput proteomics technology has been used to identify underlying mechanisms associated with the initiation and development of numerous types of cerebral disease (22)(23)(24). However, to the best of our knowledge, few studies have investigated the molecular mechanism of bilirubin-induced neurotoxicity based on proteomics techniques or extracellular MV/e (12,25,26).…”

Metallomics‐based platforms for comparing the human blood serum profiles between bipolar disorder and schizophrenia patients

“…Xiong et al also identified that this protein was differentially abundant, but its role in this mood disorder was not elucidated. 58 Regarding beta-2-glycoprotein 1 (or ApoH), the levels of this protein are admittedly elevated in SCZ patients. 59 For instance, ApoH has been suggested as a specific biomarker for SCZ or other psychotic disorders, or predisposition thereto.…”

Identification of perioperative neurocognitive dysfunction biomarkers in cerebrospinal fluid with quantitative proteomic approach in patients undergoing transurethral resection of prostate with combined spinal and epidural analgesia

“…The aim of this study was to identify differential expressed proteins (DEPs) with proteomic approach between PND and non-PND patients who underwent transurethral resection of the prostate (TURP) under combined spinal and epidural analgesia to identify potential predictors of PND, which was done through isobaric tags for relative and absolute quantitative (iTRAQ) technology. iTRAQ was a quantitative proteomic approach developed on recent years [21] and a powerful tool in not only characterizing protein expression profile but also biomarker identification. Thus far few researches regarding the proteomic profile of PND have been reported.…”